发明名称 |
PREVENTION AND TREATMENT OF HYPERGASTRINEMIA |
摘要 |
Serum-associated hypergastrinemia is treated by administration of gastrin active or passive immunization. An anti-gastrin immunogenic composition comprising a gastrin G17 or G34 peptide fragment which is amino acid spacerlinked to an immunogenic carrier, is administered so as to effectively neutralize the circulating gastrin hormone, and moreover, inhibit autocrine activity by progastrin such as Gly-extended G17, and amidated G17, in patients with pernicious anemia. Moreover, the method includes administration of a therapeutically effective amount of anti-G17 or anti-G34 antibodies which may be in humanized form. Finally, the method provides ameliorating treatment of hypergastrinemic effects of proton pump inhibitors or H2 histamine receptor blocking agents or antagonists, in addition to treatment of hypergastrinemia caused by diseases such as pernicious anemia.
|
申请公布号 |
CA2328501(A1) |
申请公布日期 |
1999.11.25 |
申请号 |
CA19992328501 |
申请日期 |
1999.05.14 |
申请人 |
APHTON CORPORATION |
发明人 |
GEVAS, PHILIP C.;GRIMES, STEPHEN;WATSON, SUSAN;MICHAELI, DOV;KARR, STEPHEN |
分类号 |
A61K39/385;A61K38/00;A61K38/22;A61K47/48;A61P7/00;A61P37/04;C07K7/06;C07K7/08;C07K14/595;C07K16/26;C07K16/40;(IPC1-7):A61K39/385 |
主分类号 |
A61K39/385 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|